According to WiseGuy Reports, the Vitamin K3 Market was valued at USD 702.0 million in 2024 and reached USD 737.1 million in 2025. The market is projected to grow to USD 1,200.0 million by 2035, registering a CAGR of 5.0% during the 2026–2035 forecast period. Growing health awareness, increasing demand for dietary supplements, rising investments in research and development, strict regulatory frameworks, and expanding pharmaceutical applications are supporting market growth. Key companies profiled include Kappa Bioscience, Nanjing Healthway Pharmaceutical, Nexira, BASF, DSM Nutritional Products, Jiangsu Jincheng Pharmaceutical, Hubei Huitian Biotech, and Ginkgo BioWorks.

Market Overview

Vitamin K3, also known as menadione, is a synthetic form of vitamin K used across pharmaceutical, nutraceutical, and animal feed applications. Its role in supporting vitamin K-related functions has made it an important ingredient for selected healthcare and nutritional formulations. The market is influenced by developments in supplementation, animal nutrition, pharmaceutical manufacturing, and functional ingredient production.

The market is segmented by application, formulation type, end-use industry, distribution channel, and region. Pharmaceuticals, nutraceuticals, and animal feed represent the primary application categories, while liquid, powder, and tablet forms serve different product requirements. Healthcare, food and beverage, and agriculture are key end-use industries.

Market Size Reached in 2025

The Vitamin K3 Market reached USD 737.1 million in 2025, increasing from USD 702.0 million in 2024. This growth reflects rising demand for vitamin-based ingredients across healthcare and nutritional applications.

The pharmaceutical sector remains an important source of demand as manufacturers use vitamin K-related compounds in selected formulations. Growing awareness of nutritional requirements is also encouraging interest in vitamin supplementation, supporting opportunities in nutraceutical products.

Animal feed represents another significant application area. Vitamin K plays a role in animal nutrition, and increasing focus on livestock health and feed quality can contribute to demand for vitamin K3 ingredients. Expanding agricultural production and professional animal husbandry practices may further support this segment.

Expected Market Size by 2035

The market is projected to reach USD 1.2 billion by 2035. Expansion is expected to be supported by the increasing dietary supplement market, pharmaceutical applications, animal nutrition requirements, and technological improvements in vitamin production.

The growing demand for animal feed provides an important market opportunity. As livestock and poultry producers focus on nutritional efficiency and animal health, demand for specialized feed additives and vitamins can increase.

Pharmaceutical applications are also expected to contribute to future growth. Continued research into vitamin K-related formulations may expand its use across specific healthcare applications, while improvements in manufacturing processes can support consistent product quality and supply.

Market CAGR

The Vitamin K3 Market is expected to grow at a CAGR of 5.0% from 2026 to 2035. This moderate growth trajectory reflects continued demand across multiple end-use sectors and the established role of vitamin ingredients in nutritional and pharmaceutical formulations.

Manufacturing innovation is expected to remain important throughout the forecast period. Producers are focusing on improving production efficiency, quality control, formulation compatibility, and supply reliability. These developments can help meet the requirements of pharmaceutical, nutraceutical, and feed manufacturers.

Key Growth Drivers

Growing health awareness is one of the primary factors supporting the market. Consumers are increasingly paying attention to nutritional requirements and preventive health, contributing to interest in dietary supplements and vitamin-based products.

The expansion of the dietary supplements industry is another important driver. Growing availability of supplements through pharmacies, retail outlets, and online platforms is improving consumer access to vitamin products.

Increasing investment in research and development is also contributing to market advancement. Manufacturers and research organizations are exploring improved production processes, formulations, and applications that can strengthen the commercial potential of vitamin K3.

Expanding pharmaceutical applications provide additional growth opportunities. Vitamin K compounds are relevant to specific healthcare requirements, creating continuing demand from pharmaceutical manufacturers.

Regulatory frameworks also play an important role. Quality, safety, manufacturing, and labeling requirements influence product development and market participation, encouraging manufacturers to strengthen compliance and quality-control systems.

Emerging Market Trends

The growing importance of animal nutrition is a notable market trend. Feed manufacturers are increasingly incorporating specialized nutritional ingredients into formulations designed to support livestock and poultry health, creating opportunities for vitamin K3 suppliers.

Another trend is the increasing availability of supplements through online channels. E-commerce platforms provide consumers with convenient access to nutritional products and allow manufacturers to reach broader markets.

Production technology is also advancing. Manufacturers are investing in improved processes designed to enhance efficiency, consistency, and product quality. These developments may help address increasing demand while supporting more reliable supply chains.

The nutraceutical industry is continuing to diversify as consumers seek targeted nutritional products. This trend may create additional opportunities for vitamin K3-based formulations where appropriate, particularly as manufacturers develop products addressing specific nutritional needs.

Competitive Landscape

The competitive landscape includes pharmaceutical, nutritional ingredient, biotechnology, and specialty chemical companies. Kappa Bioscience, Nanjing Healthway Pharmaceutical, Nexira, Shangdong Hualu Pharmaceutical, Jiangsu Jincheng Pharmaceutical, Hubei Huitian Biotech, BASF, Anhui Huanxin BioTech, Hubei Xinghua Pharmaceutical, DSM Nutritional Products, Jiangxi Maanchi, and Ginkgo BioWorks are among the companies profiled.

Competition is influenced by production capabilities, product quality, technological expertise, regulatory compliance, pricing, distribution networks, and supply reliability. Manufacturers are increasingly focusing on process optimization and product development to serve pharmaceutical, nutritional, and agricultural customers.

Geographic expansion is also expected to influence competitive strategies. Companies with established manufacturing facilities and distribution networks across major pharmaceutical and agricultural markets may be better positioned to respond to changing regional demand.

The Vitamin K3 Market is positioned for steady expansion through 2035 as healthcare awareness, dietary supplementation, pharmaceutical applications, and animal nutrition requirements continue to support demand. With the market projected to increase from USD 737.1 million in 2025 to USD 1.2 billion by 2035 at a CAGR of 5.0%, advances in production technology and expanding applications are expected to remain key factors shaping the industry's future.